Meinian Onehealth Hits Day Low of CNY 5.47 Amid Price Pressure

Meinian Onehealth Healthcare Holdings Co., Ltd. experienced a notable decline today, with the stock dropping by 3.51% on June 2, 2026. The stock reached an intraday low of CNY 5.47, reflecting ongoing challenges in its financial performance. Over the past year, the company has generated a return of 10.04%, significantly underperforming the China Shanghai Composite, which saw returns of 21.74%. The company's recent financial results have raised concerns, particularly following a negative pre-tax profit of CNY -278.08 million, marking a drastic decline of 316.01%. Additionally, net profit fell to CNY -249.87 million, a staggering drop of 479.44%. Despite being net-debt free, Meinian Onehealth's return on equity stands at a modest 4.85%, indicating low profitability relative to shareholder funds. The stock's price-to-book ratio of 3.02 suggests a high valuation, further complicating its market position. With a market capitalization of CNY 23,863 million, the company continues to navigate a challenging landscape within the pharmaceuticals and biotechnology sector.